Andreas Jonsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andreas Jonsson has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Claes Hjalmarsson
Department of Surgery, Halland Hospital Varberg, Varberg, Sweden
2 shared publicationsPeter Falk
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
2 shared publicationsEva Angenete
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, SSORG - Scandinavian Surgical Outcomes Research Group, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital/Östra, Department of Surgery, Gothenburg, Sweden
1 shared publicationMarie-Lois Ivarsson
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
1 shared publication- Marie-Lois Ivarsson
Hallands Hospital Varberg, Region Halland, SE-432 37 Varberg, Sweden
1 shared publication
Latest Publications
- Open Access
- 1 October 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 266, 254-260
Plasma MMP-1 Expression as a Prognostic Factor in Colon Cancer
- 1 October 2021
- Published by Elsevier in Journal of Surgical Research
- Vol. 266, 254-260
Open AccessPlasma MMP-1 Expression as a Prognostic Factor in Colon Cancer
- Open Access
- 17 May 2016
- Published by Springer Nature in British Journal of Cancer
- Vol. 115 (6) , 703-706
Levels of matrix metalloproteinases differ in plasma and serum – aspects regarding analysis of biological markers in cancer
The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.
- 17 May 2016
- Published by Springer Nature in British Journal of Cancer
- Vol. 115 (6) , 703-706
Open AccessLevels of matrix metalloproteinases differ in plasma and serum – aspects regarding analysis of biological markers in cancer
The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.